You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

PYRIDOSTIGMINE BROMIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for pyridostigmine bromide and what is the scope of freedom to operate?

Pyridostigmine bromide is the generic ingredient in three branded drugs marketed by Bausch, Sandoz, Amneal, Milla Pharms, MSN, Novitium Pharma, Rising, Alvogen, Impax Labs Inc, Ani Pharms, Impax Labs, MLV, Solvay, Us Army, and Zydus Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pyridostigmine bromide. Twenty-two suppliers are listed for this compound.

Summary for PYRIDOSTIGMINE BROMIDE
US Patents:0
Tradenames:3
Applicants:15
NDAs:20
Drug Master File Entries: 11
Finished Product Suppliers / Packagers: 22
Raw Ingredient (Bulk) Api Vendors: 117
Clinical Trials: 21
Patent Applications: 1,899
What excipients (inactive ingredients) are in PYRIDOSTIGMINE BROMIDE?PYRIDOSTIGMINE BROMIDE excipients list
DailyMed Link:PYRIDOSTIGMINE BROMIDE at DailyMed
Recent Clinical Trials for PYRIDOSTIGMINE BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Vermont Medical CenterPhase 2
Stefan Holubar MD MS FACS, FASCRSPhase 2/Phase 3
Michael E. DeBakey VA Medical CenterEarly Phase 1

See all PYRIDOSTIGMINE BROMIDE clinical trials

Pharmacology for PYRIDOSTIGMINE BROMIDE
Medical Subject Heading (MeSH) Categories for PYRIDOSTIGMINE BROMIDE
Anatomical Therapeutic Chemical (ATC) Classes for PYRIDOSTIGMINE BROMIDE

US Patents and Regulatory Information for PYRIDOSTIGMINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040502-001 Apr 24, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Msn PYRIDOSTIGMINE BROMIDE pyridostigmine bromide SYRUP;ORAL 216512-001 Sep 21, 2023 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz REGONOL pyridostigmine bromide INJECTABLE;INJECTION 017398-001 Approved Prior to Jan 1, 1982 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040502-002 Jun 28, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch MESTINON pyridostigmine bromide SYRUP;ORAL 015193-001 Approved Prior to Jan 1, 1982 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alvogen PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 204737-001 Jun 26, 2015 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Solvay PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 089572-001 Nov 27, 1990 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.